{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T12:40:33Z","timestamp":1687437633745},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,15]]},"DOI":"10.1097\/qad.0b013e328352ae2f","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T06:57:48Z","timestamp":1336028268000},"page":"1035-1036","source":"Crossref","is-referenced-by-count":2,"title":["HIV protease inhibitors to prevent progression of cervical intraepithelial neoplasia to cervical cancer"],"prefix":"10.1097","volume":"26","author":[{"given":"Joel","family":"Palefsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-16-20210130","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with AIDS-related immunosuppression in adults.","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"R3-16-20210130","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jnci\/djp205","article-title":"Risk of human papillomavirus-associated cancers among persons with AIDS.","volume":"101","author":"Chaturvedi","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R4-16-20210130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States.","volume":"103","author":"Shiels","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R5-16-20210130","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6-16-20210130","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males: Advisory Committee on Immunization Practices (ACIP), 2011.","volume":"60","author":"Dunne","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-16-20210130","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00404-011-1848-3","article-title":"Obstetric outcome following cervical conization.","volume":"283","author":"Armarnik","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"R8-16-20210130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/QAD.0b013e328351f7a5","article-title":"Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity.","volume":"26","author":"Barillari","year":"2012","journal-title":"AIDS"},{"key":"R9-16-20210130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QAD.0b013e328331f6e2","article-title":"Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.","volume":"24","author":"Crum-Cianflone","year":"2010","journal-title":"AIDS"},{"key":"R10-16-20210130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/COH.0b013e32831a7246","article-title":"Human papillomavirus-related disease in people with HIV.","volume":"4","author":"Palefsky","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"R11-16-20210130","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/00002030-200111090-00011","article-title":"The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.","volume":"15","author":"Minkoff","year":"2001","journal-title":"AIDS"},{"key":"R13-16-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/135965350400900117","article-title":"The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.","volume":"9","author":"Heard","year":"2004","journal-title":"Antivir Ther"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e328352ae2f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T12:11:49Z","timestamp":1687435909000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201205150-00016"}},"subtitle":["therapeutic opportunities and challenges"],"short-title":[],"issued":{"date-parts":[[2012,5,15]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328352ae2f","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,15]]}}}